Loading
A phase 2 trial of Electrochemotherapy in Vulvar cancer, run by Institute of Oncology Ljubljana, now recruiting.
Electrochemotherapy for Recurrent Vulvar Cancer is a phase 2 interventional study registered as NCT07443475 by Institute of Oncology Ljubljana, with 13 participants planned, started 2021-09-01 and due to reach its primary completion in 2026-08-31. Interventions recorded: Electrochemotherapy (ECT). Conditions recorded: Vulvar Cancer, Recurrent Vulvar Cancer.
Linked to the technology Electrochemotherapy because the registry names it ("electrochemotherapy") among its interventions and Vulvar cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Electrochemotherapy, Vulvar cancer and the tag pipeline.
Shares Electrochemotherapy and the tag pipeline.
Shares Vulvar cancer and the tag pipeline.
Shares Vulvar cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/